Oxford Endovascular

Oxford, United Kingdom

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

$10.2M raised

May 2024

Series A

Biotechnology Health Care Medical

Top Investors

Innovate UKParkwalk AdvisorsOxford Science EnterprisesUniversity of OxfordEASME

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Oxford Endovascular

How much funding has Oxford Endovascular raised?

Oxford Endovascular has raised $10.2M in total funding. The most recent round was Series A. The last funding was announced in May 2024.

Who are Oxford Endovascular's investors?

Oxford Endovascular's investors include Innovate UK, Parkwalk Advisors, Oxford Science Enterprises, University of Oxford, EASME.

Where is Oxford Endovascular headquartered?

Oxford Endovascular is headquartered in Oxford, United Kingdom.

What does Oxford Endovascular do?

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

What stage is Oxford Endovascular at?

Oxford Endovascular is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 20, 2024.

MLA

"Oxford Endovascular — Funding & Investors." VCBacked, May 20, 2024, https://www.vcbacked.co/company/oxford-endovascular. Accessed June 4, 2026.

APA

VCBacked. (2024). Oxford Endovascular — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/oxford-endovascular

Wikipedia (cite web)

{{cite web |title=Oxford Endovascular — Funding & Investors |url=https://www.vcbacked.co/company/oxford-endovascular |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 20, 2024.

Similar Companies in Biotechnology